SC suggests meeting of stakeholders to discuss quality, shortage of antiretroviral drugs for HIV patients
New Delhi: The Supreme Court has made a suggestion of conducting a meeting between the Centre, National AIDS Control Organisation (NACO), and an organisation dedicated to AIDS patients to address concerns regarding the quality and shortage of antiretroviral drugs used in the treatment of HIV.
The bench overseeing the case, composed of Chief Justice D Y Chandrachud and Justices JB Pardiwala and Manoj Misra, was hearing a Public Interest Litigation (PIL) filed in 2022 by the NGO 'Network of People Living with HIV/AIDS'. The PIL alleged a shortage of antiretroviral drugs for HIV patient treatment.
Referring to the shortage of antiretroviral drugs in the country during the COVID-19 pandemic, the bench noted the submissions of Additional Solicitor General Aishwarya Bhati, appearing for the Centre, and senior advocate Anand Grover, representing the petitioner NGO, and said "dust has now settled" and there were enough medicines available.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.